Digital therapeutics for Substance Use Disorders: Research priorities and clinical validation.

Aklin, Will M; Walton, Kevin M; Antkowiak, Patrick

Aklin, Will M; Walton, Kevin M; Antkowiak, Patrick.

Afiliação

Aklin WM; National Institute on Drug Abuse, Division of Therapeutics and Medical Consequences, United States. Electronic address: aklinwm@mail.nih.gov.
Walton KM; National Institute on Drug Abuse, Division of Therapeutics and Medical Consequences, United States.
Antkowiak P; Food and Drug Administration, Center for Devices and Radiological Health, Office of Neurological and Physical Medicine Devices, United States.

Drug Alcohol Depend ; 229(Pt A): 109120, 2021 12 01.

Article em En | MEDLINE | ID: mdl-34740068

Assuntos

Transtornos Relacionados ao Uso de Substâncias; Humanos; Pesquisa; Transtornos Relacionados ao Uso de Substâncias/terapia

Palavras-chave

Behavioral interventions; Digital therapeutics; FDA authorization process

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google